Update on the use of systemic biologic agents in the treatment of noninfectious uveitis

References

• JabsDANussenblattRBRosenbaumJTStandardization of uveitis nomenclature for reporting clinical data. Results of the First International WorkshopAm J Ophthalmol2005140350951616196117
   PubMed Web of Science ®Google Scholar
• WakefieldDChangJHEpidemiology of uveitisInt Ophthalmol Clin200545211315791154
   PubMedGoogle Scholar
• JabsDARosenbaumJTFosterCSGuidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAm J Ophthalmol2000130449251311024423
   PubMed Web of Science ®Google Scholar
• PasadhikaSKempenJHNewcombCWAzathioprine for ocular inflammatory diseasesAm J Ophthalmol20091484500509.e219570522
   PubMed Web of Science ®Google Scholar
• GangaputraSNewcombCWLiesegangTLMethotrexate for ocular inflammatory diseasesOphthalmology20091161121882198.e119748676
   PubMed Web of Science ®Google Scholar
• PujariSSKempenJHNewcombCWCyclophosphamide for ocular inflammatory diseasesOphthalmology2010117235636519969366
   PubMed Web of Science ®Google Scholar
• KacmazROKempenJHNewcombCCyclosporine for ocular inflammatory diseasesOphthalmology2010117357658420031223
   PubMed Web of Science ®Google Scholar
• DanielEThorneJENewcombCWMycophenolate mofetil for ocular inflammationAm J Ophthalmol20101493423432e1e220042178
   PubMed Web of Science ®Google Scholar
• SfikakisPPTheodossiadisPGKatsiariCGKaklamanisPMarkomichelakisNNEffect of infliximab on sight-threatening panuveitis in Behcet’s diseaseLancet2001358927829529611498218
   PubMed Web of Science ®Google Scholar
• OhnoSNakamuraSHoriSEfficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet’s disease with refractory uveoretinitisJ Rheumatol20043171362136815229958
   PubMed Web of Science ®Google Scholar
• SuhlerEBSmithJRWertheimMSA prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomesArch Ophthalmol2005123790391216009830
   PubMedGoogle Scholar
• SfikakisPPKaklamanisPHElezoglouAInfliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet diseaseAnn Intern Med2004140540440614996689
   PubMed Web of Science ®Google Scholar
• MarkomichelakisNDelichaEMasselosSA single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behcet’s disease: a comparative 4-week studyRheumatology (Oxford)201150359359721097877
   PubMed Web of Science ®Google Scholar
• TabbaraKFAl-HemidanAIInfliximab effects compared to conventional therapy in the management of retinal vasculitis in Behcet diseaseAm J Ophthalmol20081466845850.e118929351
   PubMed Web of Science ®Google Scholar
• KahnPWeissMImundoLFLevyDMFavorable response to high-dose infliximab for refractory childhood uveitisOphthalmology20061135860864.e216545455
   PubMed Web of Science ®Google Scholar
• RajaramanRTKimuraYLiSHainesKChuDSRetrospective case review of pediatric patients with uveitis treated with infliximabOphthalmology2006113230831416406545
   PubMed Web of Science ®Google Scholar
• RichardsJCTay-KearneyMLMurrayKMannersPInfliximab for juvenile idiopathic arthritis-associated uveitisClin Experiment Ophthalmol200533546146816181269
   PubMed Web of Science ®Google Scholar
• TynjalaPLindahlPHonkanenVLahdennePKotaniemiKInfliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritisAnn Rheum Dis200766454855017068061
   PubMed Web of Science ®Google Scholar
• PasadhikaSSuhlerEBCunninghamETUse of biologic agents in the treatment of uveitisReview of Ophthalmology: Retinal Insider20104652
   Google Scholar
• BaughmanRPBradleyDALowerEEInfliximab in chronic ocular inflammationInt J Clin Pharmacol Ther200543171115704608
   PubMed Web of Science ®Google Scholar
• PritchardCNadarajahKTumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patientsAnn Rheum Dis200463331832014962969
   PubMed Web of Science ®Google Scholar
• DotyJDMazurJEJudsonMATreatment of sarcoidosis with infliximabChest200512731064107115764796
   PubMed Web of Science ®Google Scholar
• Benitez-del-CastilloJMMartinez-de-la-CasaJMPato-CourELong-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab)Eye (Lond)200519884184515389273
   PubMed Web of Science ®Google Scholar
• FriesWGiofreMRCatanosoMLo GulloRTreatment of acute uveitis associated with Crohn’s disease and sacroileitis with infliximabAm J Gastroenterol200297249950011866306
   PubMed Web of Science ®Google Scholar
• RispoAScarpaRDi GirolamoEInfliximab in the treatment of extra-intestinal manifestations of Crohn’s diseaseScand J Rheumatol200534538739116234187
   PubMed Web of Science ®Google Scholar
• AllyMRVeerappanGRKoffJMTreatment of recurrent Crohn’s uveitis with infliximabAm J Gastroenterol200810382150215118796120
   PubMed Web of Science ®Google Scholar
• BodaghiBBui QuocEWechslerBTherapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factorsAnn Rheum Dis200564696296415897316
   PubMed Web of Science ®Google Scholar
• JollyMCurranJJInfliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritisJ Clin Rheumatol200511421321516357759
   PubMed Web of Science ®Google Scholar
• ArtornsombudhPGevorgyanOPayalASiddiqueSSFosterCSInfliximab treatment of patients with birdshot retinochoroidopathyOphthalmology2013120358859223177362
   PubMed Web of Science ®Google Scholar
• MarkomichelakisNNTheodossiadisPGPanteliaEInfliximab for chronic cystoid macular edema associated with uveitisAm J Ophthalmol2004138464865015488796
   PubMed Web of Science ®Google Scholar
• El-ShabrawiYHermannJAnti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitisOphthalmology2002109122342234612466181
   PubMed Web of Science ®Google Scholar
• KruithofEKestelynPElewautCSuccessful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitisAnn Rheum Dis200261547011959776
   PubMed Web of Science ®Google Scholar
• GuptaSRPhanITSuhlerEBSuccessful treatment of refractory sympathetic ophthalmia in a child with infliximabArch Ophthalmol2011129225025221320978
   PubMedGoogle Scholar
• AdanASanmartiRBuresACasaroli-MaranoRPSuccessful treatment with infliximab in a patient with diffuse subretinal fibrosis syndromeAm J Ophthalmol2007143353353417317410
   PubMed Web of Science ®Google Scholar
• LindstedtEWBaarsmaGSKuijpersRWvan HagenPMAnti-TNF-alpha therapy for sight threatening uveitisBr J Ophthalmol200589553353615834077
   PubMed Web of Science ®Google Scholar
• SuhlerEBSmithJRGilesTRInfliximab therapy for refractory uveitis: 2-year results of a prospective trialArch Ophthalmol2009127681982219506209
   PubMed Web of Science ®Google Scholar
• ClementineRRLymanJZakemJTumor necrosis factor-alpha antagonist-induced sarcoidosisJ Clin Rheumatol201016627427920808167
   PubMed Web of Science ®Google Scholar
• OlivierAGilsonBLafontaineSPautotJXBindiPPulmonary and renal involvement in a TNFα antagonist drug-induced sarcoidosisRev Med Interne2012335e25e27 French21592629
   PubMedGoogle Scholar
• IzziSFrancesconiFViscaPPulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapyDermatol Online J20101651620492833
   PubMedGoogle Scholar
• DaienCIMonnierAClaudepierrePSarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 casesRheumatology (Oxford)200948888388619423648
   PubMed Web of Science ®Google Scholar
• DhailleFViseuxVCaudronACutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two casesDermatology2010220323423720185892
   PubMed Web of Science ®Google Scholar
• TakahashiHKanetaKHonmaMSarcoidosis during infliximab therapy for Crohn’s diseaseJ Dermatol201037547147420536653
   PubMed Web of Science ®Google Scholar
• MetyasSKTadrosRMArkfeldDGAdalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritisRheumatol Int200929443743918762943
   PubMed Web of Science ®Google Scholar
• JavotLTalaSScala-BertolaJSarcoïdosis and anti-TNF: a paradoxical class effect? Analysis of the French Pharmacovigilance system database and literature reviewTherapie2011662149154 French21635863
   PubMed Web of Science ®Google Scholar
• CunninghamETJrPasadhikaSSuhlerEBZierhutMDrug-induced inflammation in patients on TNFα inhibitorsOcul Immunol Inflamm20122012522324894
   PubMed Web of Science ®Google Scholar
• Cordero-ComaMBenitoMFHernandezAMAntolinSCRuizJMSerpiginous choroiditisOphthalmology2008115916331633.e1e218762076
   PubMed Web of Science ®Google Scholar
• SevePMennessonEGrangeJDBroussolleCKodjikianLInfliximab in serpiginous choroiditisActa Ophthalmol2010888e342e34319799587
   PubMed Web of Science ®Google Scholar
• MackensenFBeckerMDWiehlerUQuantiFERON TB-Gold – a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditisAm J Ophthalmol2008146576176618718569
   PubMed Web of Science ®Google Scholar
• PasadhikaSSuhlerEBCunninghamETBiologic therapy for posterior uveitis and panuveitisRetina Today20127479
   Google Scholar
• Vazquez-CobianLBFlynnTLehmanTJAdalimumab therapy for childhood uveitisJ Pediatr2006149457257517011337
   PubMed Web of Science ®Google Scholar
• BiesterSDeuterCMichelsHAdalimumab in the therapy of uveitis in childhoodBr J Ophthalmol200791331932417035274
   PubMed Web of Science ®Google Scholar
• SimoniniGTaddioACattaliniMSuperior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitisPediatr Rheumatol Online J20131111623587261
   PubMed Web of Science ®Google Scholar
• TynjalaPKotaniemiKLindahlPAdalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitisRheumatology (Oxford)200847333934418238789
   PubMed Web of Science ®Google Scholar
• MushtaqBSaeedTSitunayakeRDMurrayPIAdalimumab for sight-threatening uveitis in Behcet’s diseaseEye (Lond)200721682482516601736
   PubMed Web of Science ®Google Scholar
• BawazeerARaffaLHNizamuddinSHClinical experience with adalimumab in the treatment of ocular Behcet diseaseOcul Immunol Inflamm201018322623220482404
   PubMed Web of Science ®Google Scholar
• Diaz-LlopisMGarcia-DelpechSSalomDAdalimumab therapy for refractory uveitis: a pilot studyJ Ocul Pharmacol Ther200824335136118476805
   PubMed Web of Science ®Google Scholar
• SuhlerEBLowderCYGoldsteinDAAdalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trialBr J Ophthalmol201397448148623376607
   PubMed Web of Science ®Google Scholar
• Diaz-LlopisMSalomDGarcia-de-VicunaCTreatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patientsOphthalmology201211981575158122525047
   PubMed Web of Science ®Google Scholar
• RudwaleitMRodevandEHolckPAdalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label studyAnn Rheum Dis200968569670118662932
   PubMed Web of Science ®Google Scholar
• ReiffATakeiSSadeghiSEtanercept therapy in children with treatment-resistant uveitisArthritis Rheum20014461411141511407702
   PubMed Web of Science ®Google Scholar
• QuartierPTaupinPBourdeautFEfficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typeArthritis Rheum20034841093110112687553
   PubMed Web of Science ®Google Scholar
• SmithJAThompsonDJWhitcupSMA randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritisArthritis Rheum2005531182315696578
   PubMed Web of Science ®Google Scholar
• FosterCSTufailFWaheedNKEfficacy of etanercept in preventing relapse of uveitis controlled by methotrexateArch Ophthalmol2003121443744012695239
   PubMed Web of Science ®Google Scholar
• GalorAPerezVLHammelJPLowderCYDifferential effectiveness of etanercept and infliximab in the treatment of ocular inflammationOphthalmology2006113122317232316996615
   PubMed Web of Science ®Google Scholar
• TabanMDuppsWJMandellBPerezVLEtanercept (enbrel)-associated inflammatory eye disease: case report and review of the literatureOcul Immunol Inflamm200614314515016766397
   PubMed Web of Science ®Google Scholar
• WangFWangNSEtanercept therapy-associated acute uveitis: a case report and literature reviewClin Exp Rheumatol200927583883919917170
   PubMed Web of Science ®Google Scholar
• LimLLFraunfelderFWRosenbaumJTDo tumor necrosis factor inhibitors cause uveitis? A registry-based studyArthritis Rheum200756103248325217907169
   PubMed Web of Science ®Google Scholar
• Cordero-ComaMSalomDDiaz-LlopisMLopez-PratsMJCallejaSGolimumab for uveitisOphthalmology201111891892.e3e421889663
   PubMed Web of Science ®Google Scholar
• WilliamMFaezSPapaliodisGNLoboAMGolimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitisJ Ophthalmic Inflamm Infect20122423123322581347
   PubMedGoogle Scholar
• MiserocchiEModoratiGPontikakiIMeroniPGerloniVGolimumab treatment for complicated uveitisClin Exp Rheumatol201331232032123331715
   PubMed Web of Science ®Google Scholar
• MesquidaMVictoria HernandezMLlorencVBehcet disease-associated uveitis successfully treated with golimumabOcul Immunol Inflamm201321216016223252659
   PubMed Web of Science ®Google Scholar
• FaezSLoboAMSobrinLPapaliodisGNTreatment of seronegative spondyloarthropathy-associated uveitis with golimumab: retrospective case seriesClin Experiment Ophthalmol Epub9112013
   Web of Science ®Google Scholar
• TlucekPSStoneDUCertolizumab pegol therapy for rheumatoid arthritis-associated scleritisCornea2012311909121941174
   PubMed Web of Science ®Google Scholar
• NussenblattRBFortinESchiffmanRTreatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a Phase I/II clinical trialProc Natl Acad Sci U S A199996137462746610377437
   PubMed Web of Science ®Google Scholar
• NussenblattRBThompsonDJLiZHumanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administrationJ Autoimmun200321328329314599854
   PubMed Web of Science ®Google Scholar
• NussenblattRBPetersonJSFosterCSInitial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case seriesOphthalmology2005112576477015878055
   PubMed Web of Science ®Google Scholar
• SobrinLHuangJJChristenWDaclizumab for treatment of birdshot chorioretinopathyArch Ophthalmol2008126218619118268208
   PubMed Web of Science ®Google Scholar
• YehSWroblewskiKBuggageRHigh-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitisJ Autoimmun2008312919718571896
   PubMed Web of Science ®Google Scholar
• SenHNLevy-ClarkeGFaiaLJHigh-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitisAm J Ophthalmol20091485696703.e69119664754
   PubMed Web of Science ®Google Scholar
• BuggageRRLevy-ClarkeGSenHNA double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behcet’s diseaseOcul Immunol Inflamm2007152637017558830
   PubMed Web of Science ®Google Scholar
• KurzPASuhlerEBChoiDRosenbaumJTRituximab for treatment of ocular inflammatory disease: a series of four casesBr J Ophthalmol200993454654819321476
   PubMed Web of Science ®Google Scholar
• OnalSKazokogluHKocAYavuzSRituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener’s granulomatosisOcul Immunol Inflamm200816523023219065418
   PubMed Web of Science ®Google Scholar
• IaccheriBAndroudiSBocciEBRituximab treatment for persistent scleritis associated with rheumatoid arthritisOcul Immunol Inflamm201018322322520482403
   PubMed Web of Science ®Google Scholar
• SadreddiniSNoshadHMolaeefardMNoshadRTreatment of retinal vasculitis in Behcet’s disease with rituximabMod Rheumatol200818330630818438602
   PubMed Web of Science ®Google Scholar
• DavatchiFShamsHRezaipoorMRituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)Int J Rheum Dis201013324625220704622
   PubMed Web of Science ®Google Scholar
• MiserocchiEPontikakiIModoratiGRituximab for uveitisOphthalmology2011118122322421199719
   PubMed Web of Science ®Google Scholar
• HeiligenhausAMiserocchiEHeinzCGerloniVKotaniemiKTreatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)Rheumatology (Oxford)20115081390139421378109
   PubMed Web of Science ®Google Scholar
• Tomkins-NetzerOTaylorSRLightmanSCan rituximab induce long-term disease remission in patients with intra-ocular non-infectious inflammation?Ophthalmologica2013230310911523948944
   PubMed Web of Science ®Google Scholar
• NicholsonLSobrinLAnterior uveitis secondary to type II essential cryoglobulinemiaJ Ophthalmic Inflamm Infect2013315623883484
   PubMedGoogle Scholar
• Angeles-HanSFlynnTLehmanTAbatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case reportJ Rheumatol20083591897189818785302
   PubMed Web of Science ®Google Scholar
• ZulianFBalzarinMFalciniFAbatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitisArthritis Care Res (Hoboken)201062682182520191477
   PubMed Web of Science ®Google Scholar
• ElhaiMDeslandreCJKahanAAbatacept for refractory juvenile idiopathic arthritis-associated uveitis: two new cases. Comment on the article by Zulian et alArthritis Care Res (Hoboken)2011632307308 author reply 30820890986
   PubMed Web of Science ®Google Scholar
• KenawyNClearyGMewarDAbatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitisGraefes Arch Clin Exp Ophthalmol2011249229730020922440
   PubMed Web of Science ®Google Scholar
• SuhlerEBGilesTRHanelSAA phase I/II dose-ranging, randomized clinical trial of abatacept (Orencia) in the treatment of refractory non-infectious uveitis: preliminary resultsProceedings of the Association for Research in Vision and Ophthalmology Annual MeetingMay 5–9, 2013Washington, USA
   Google Scholar
• BirnbaumFJehleTSchwartzkopffJBasiliximab following penetrating risk-keratoplasty – a prospective randomized pilot studyKlin Monbl Augenheilkd200822516265 German18236372
   PubMed Web of Science ®Google Scholar
• LimWKFujimotoCUrseaRSuppression of immune-mediated ocular inflammation in mice by interleukin 1 receptor antagonist administrationArch Ophthalmol2005123795796316009838
   PubMedGoogle Scholar
• TeohSCSharmaSHoganATailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndromeBr J Ophthalmol200791226326417244662
   PubMed Web of Science ®Google Scholar
• UgurluSUcarDSeyahiEHatemiGYurdakulSCanakinumab in a patient with juvenile Behcet’s syndrome with refractory eye diseaseAnn Rheum Dis20127191589159122586166
   PubMed Web of Science ®Google Scholar
• SimoniniGXuZCaputoRClinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitisArthritis Rheum201365251351823124805
   PubMed Web of Science ®Google Scholar
• GulATugal-TutkunIDinarelloCAInterleukin-1beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet’s disease: an open-label pilot studyAnn Rheum Dis201271456356622084392
   PubMed Web of Science ®Google Scholar
• TappeinerCHeinzCGanserGHeiligenhausAIs tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?J Rheumatol20123961294129522661419
   PubMed Web of Science ®Google Scholar
• HiranoTOhguroNHohkiSA case of Behcet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumabMod Rheumatol201222229830221748365
   PubMed Web of Science ®Google Scholar
• AdanAMesquidaMLlorencVModestoCTocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: a case reportGraefes Arch Clin Exp Ophthalmol Epub9242013
   Web of Science ®Google Scholar
• OshitariTKajitaFTobeARefractory uveitis in patient with castleman disease successfully treated with tocilizumabCase Rep Ophthalmol Med2012201296818023198204
   PubMedGoogle Scholar
• AdanAMesquidaMLlorencVTocilizumab treatment for refractory uveitis-related cystoid macular edemaGraefes Arch Clin Exp Ophthalmol2013251112627263223893042
   PubMed Web of Science ®Google Scholar
• WendlingDDernisEPratiCFrischEDelboscBOnset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?J Rheumatol20113810228421965707
   PubMed Web of Science ®Google Scholar
• IsaacsJDWattsRAHazlemanBLHumanised monoclonal antibody therapy for rheumatoid arthritisLancet199234088227487521356177
   PubMed Web of Science ®Google Scholar
• ColesAJTwymanCLArnoldDLAlemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trialLancet201238098561829183923122650
   PubMed Web of Science ®Google Scholar
• IsaacsJDHaleGWaldmannHMonoclonal antibody therapy of chronic intraocular inflammation using Campath-1HBr J Ophthalmol19957911105410558534657
   PubMed Web of Science ®Google Scholar
• DickADMeyerPJamesTCampath-1H therapy in refractory ocular inflammatory diseaseBr J Ophthalmol200084110710910611109
   PubMed Web of Science ®Google Scholar
• LockwoodCMHaleGWaldmanHJayneDRRemission induction in Behcet’s disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-HRheumatology (Oxford)200342121539154412949252
   PubMed Web of Science ®Google Scholar
• WangJIbrahimMTurkcuogluPIntercellular adhesion molecule inhibitors as potential therapy for refractory uveitic macular edemaOcul Immunol Inflamm201018539539820666682
   PubMed Web of Science ®Google Scholar
• FaiaLJSenHNLiZTreatment of inflammatory macular edema with humanized anti-CD11a antibody therapyInvest Ophthalmol Vis Sci20115296919692421498606
   PubMed Web of Science ®Google Scholar
• TalamontiMTeoliMBottiEPatients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspensionDermatology2011222325025521494026
   PubMed Web of Science ®Google Scholar
• GueudryJWechslerBTerradaCLong-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behcet diseaseAm J Ophthalmol20081466837844.e83119027420
   PubMed Web of Science ®Google Scholar
• BeckerMDHeiligenhausAHuddeTInterferon as a treatment for uveitis associated with multiple sclerosisBr J Ophthalmol200589101254125716170111
   PubMed Web of Science ®Google Scholar
• KötterIGunaydinIZierhutMStubigerNThe use of interferon alpha in Behçet disease: review of the literatureSemin Arthritis Rheum200433532033515079763
   PubMed Web of Science ®Google Scholar
• DeuterCMKoetterIGuenaydinIStuebigerNZierhutMInterferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot studyRetina200626778679116963852
   PubMed Web of Science ®Google Scholar
• DeuterCStubigerNZierhutMInterferon-alpha therapy in noninfectious uveitisDev Ophthalmol201251909722517207
   PubMedGoogle Scholar
• DoychevaDDeuterCStuebigerNZierhutMInterferon-alpha-associated presumed ocular sarcoidosisGraefes Arch Clin Exp Ophthalmol2009247567568019034483
   PubMed Web of Science ®Google Scholar
• AlazemiSCamposMAInterferon-induced sarcoidosisInt J Clin Pract200660220121116451294
   PubMed Web of Science ®Google Scholar
• NussenblattRBThe natural history of uveitisInt Ophthalmol1990145–63033082249907
   PubMed Web of Science ®Google Scholar
• RothovaASuttorp-van SchultenMSFrits TreffersWKijlstraACauses and frequency of blindness in patients with intraocular inflammatory diseaseBr J Ophthalmol19968043323368703885
   PubMed Web of Science ®Google Scholar
• SchiffmanRMJacobsenGWhitcupSMVisual functioning and general health status in patients with uveitisArch Ophthalmol2001119684184911405835
   PubMed Web of Science ®Google Scholar
• MainiRO’SullivanJReddyAWatsonSEdelstenCThe risk of complications of uveitis in a district hospital cohortBr J Ophthalmol200488451251715031168
   PubMed Web of Science ®Google Scholar
• RosenbaumJTRussellASGuentherLCEl-GabalawyHThe influence of uveitis on patients with immune-mediated inflammatory diseaseJ Rheumatol Suppl201188263022045975
   PubMedGoogle Scholar
• MindenKNiewerthMZinkALong-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBORheumatology (Oxford)20125181407141522447885
   PubMed Web of Science ®Google Scholar
• SakaiTWatanabeHKuroyanagiKHealth- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitisBr J Ophthalmol201397333834223314623
   PubMed Web of Science ®Google Scholar
• AthanasakisKPetrakisIKyriopoulosJInvestigating the value of abatacept in the treatment of rheumatoid arthritis: a systematic review of cost-effectiveness studiesISRN Rheumatol2013201325687123819062
   PubMedGoogle Scholar
• ThielMAWildASchmidMKPenetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eyeOphthalmology201312071403140823490328
   PubMed Web of Science ®Google Scholar
• StahlAStumppMTSchlegelAHighly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applicationsAngiogenesis201316110111122983424
   PubMed Web of Science ®Google Scholar
• CampochiaroPAChannaRBergerBBTreatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II studyAm J Ophthalmol20131554697704704.e1e223218689
   PubMed Web of Science ®Google Scholar
• MarkomichelakisNDelichaEMasselosSSfikakisPPIntravitreal infliximab for sight-threatening relapsing uveitis in Behcet disease: a pilot study in 15 patientsAm J Ophthalmol20121543534541.e53122789563
   PubMed Web of Science ®Google Scholar
• GigantiMBeerPMLemanskiNAdverse events after intravitreal infliximab (Remicade)Retina2010301718019996827
   PubMed Web of Science ®Google Scholar